GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Medclair AB (NGM:MCLR) » Definitions » Revenue per Share

Medclair AB (NGM:MCLR) Revenue per Share : kr0.44 (TTM As of Sep. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Medclair AB Revenue per Share?

Medclair AB's revenue per share for the three months ended in Sep. 2024 was kr0.05. Medclair AB's revenue per share for the trailing twelve months (TTM) ended in Sep. 2024 was kr0.44.

Warning Sign:

Medclair AB revenue per share has been in decline for the last 5 years.

During the past 12 months, the average Revenue Per Share Growth Rate of Medclair AB was -12.90% per year. During the past 3 years, the average Revenue Per Share Growth Rate was 78.80% per year. During the past 5 years, the average Revenue Per Share Growth Rate was -9.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate.

The historical rank and industry rank for Medclair AB's Revenue per Share or its related term are showing as below:

NGM:MCLR' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -51.1   Med: -11.8   Max: 78.8
Current: 78.8

During the past 9 years, Medclair AB's highest 3-Year average Revenue Per Share Growth Rate was 78.80% per year. The lowest was -51.10% per year. And the median was -11.80% per year.

NGM:MCLR's 3-Year Revenue Growth Rate is ranked better than
97.61% of 752 companies
in the Medical Devices & Instruments industry
Industry Median: 4 vs NGM:MCLR: 78.80

Medclair AB Revenue per Share Historical Data

The historical data trend for Medclair AB's Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medclair AB Revenue per Share Chart

Medclair AB Annual Data
Trend Apr15 Apr16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Revenue per Share
Get a 7-Day Free Trial Premium Member Only 0.65 0.08 0.13 0.30 0.43

Medclair AB Quarterly Data
Dec18 Jun19 Dec19 Jun20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.18 0.09 0.14 0.16 0.05

Competitive Comparison of Medclair AB's Revenue per Share

For the Medical Devices subindustry, Medclair AB's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medclair AB's PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medclair AB's PS Ratio distribution charts can be found below:

* The bar in red indicates where Medclair AB's PS Ratio falls into.


;
;

Medclair AB Revenue per Share Calculation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Medclair AB's Revenue Per Share for the fiscal year that ended in Dec. 2023 is calculated as

Revenue Per Share (A: Dec. 2023 )=Revenue (A: Dec. 2023 )/Shares Outstanding (Diluted Average) (A: Dec. 2023 )
=39.853/92.833
=0.43

Medclair AB's Revenue Per Share for the quarter that ended in Sep. 2024 is calculated as

Revenue Per Share (Q: Sep. 2024 )=Revenue (Q: Sep. 2024 )/Shares Outstanding (Diluted Average) (Q: Sep. 2024 )
=3.524/71.150
=0.05

Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.44

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medclair AB  (NGM:MCLR) Revenue per Share Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:

Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Medclair AB Revenue per Share Related Terms

Thank you for viewing the detailed overview of Medclair AB's Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Medclair AB Business Description

Traded in Other Exchanges
N/A
Address
Box 3113, Stockholm, SWE, 103 62
Medclair AB operates in healthcare industry. The company has two units: Central Destruction Unit (CDU) and Mobile Destruction Unit (MDU) decomposes up to 99% of the nitrous oxide entering the unit, transforming it to nitrogen (N2) och oxygen (O2). It also provide solutions for various N2O methods such as double mask, single mask, mouthpiece, or free flow, which ensures a safe work environment for healthcare professionals.

Medclair AB Headlines

No Headlines